AGL 40.10 Decreased By ▼ -0.90 (-2.2%)
AIRLINK 127.80 Decreased By ▼ -0.34 (-0.27%)
BOP 6.60 Decreased By ▼ -0.10 (-1.49%)
CNERGY 4.60 Increased By ▲ 0.08 (1.77%)
DCL 8.58 Decreased By ▼ -0.03 (-0.35%)
DFML 41.40 Increased By ▲ 0.31 (0.75%)
DGKC 86.50 Decreased By ▼ -0.63 (-0.72%)
FCCL 32.13 Decreased By ▼ -1.26 (-3.77%)
FFBL 65.40 Decreased By ▼ -0.01 (-0.02%)
FFL 10.27 Decreased By ▼ -0.20 (-1.91%)
HUBC 110.60 Decreased By ▼ -0.03 (-0.03%)
HUMNL 14.70 Decreased By ▼ -0.60 (-3.92%)
KEL 5.15 Increased By ▲ 0.17 (3.41%)
KOSM 7.15 Decreased By ▼ -0.28 (-3.77%)
MLCF 41.69 Decreased By ▼ -1.30 (-3.02%)
NBP 60.20 Decreased By ▼ -0.22 (-0.36%)
OGDC 194.48 Decreased By ▼ -3.16 (-1.6%)
PAEL 27.95 Decreased By ▼ -1.06 (-3.65%)
PIBTL 7.98 Decreased By ▼ -0.28 (-3.39%)
PPL 150.52 Decreased By ▼ -3.64 (-2.36%)
PRL 27.08 Increased By ▲ 2.08 (8.32%)
PTC 16.08 Decreased By ▼ -0.01 (-0.06%)
SEARL 78.20 Decreased By ▼ -0.25 (-0.32%)
TELE 7.42 Increased By ▲ 0.05 (0.68%)
TOMCL 35.70 Decreased By ▼ -0.39 (-1.08%)
TPLP 7.90 Decreased By ▼ -0.17 (-2.11%)
TREET 15.87 Decreased By ▼ -0.09 (-0.56%)
TRG 52.70 Decreased By ▼ -0.66 (-1.24%)
UNITY 26.65 Decreased By ▼ -0.06 (-0.22%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 9,920 Decreased By -52.1 (-0.52%)
BR30 30,751 Decreased By -346.3 (-1.11%)
KSE100 93,225 Decreased By -423.8 (-0.45%)
KSE30 28,885 Decreased By -132.9 (-0.46%)

European shares rose slightly on Friday, nearing their highest level in over two weeks, as the market was supported by a rally in drugmakers on hopes of tie-up activity in the sector. Actelion surged 16.8 percent to a record high after the Swiss biotechnology firm confirmed a report of a take-over approach from Johnson & Johnson, which also said discussions were under way.
Actelion, which has been seen as a potential takeover target for years, said there was no certainty a deal would be reached, while analysts also expressed some scepticism about the willingness of its founder and CEO Jean-Paul Clozel to sell. "We continue to believe that management ... remains committed to Actelion as an independent company," Barclays said, while Exane said a successful buyer would need to pay more than 200 CHF per share, a price above Friday's close.
Actelion's jump helped the STOXX Europe 600 Healthcare index to advance 1.4 percent, the top sector gainer in Europe as traders bet there could be further M&A in the sector. The pan-European STOXX 600 index ended up 0.2 percent. It gained 1 percent this week after rising in the previous two weeks. The index is up 2.3 percent since Donald Trump's surprise victory in the US presidential election.
Philippe Gijsels, head of research at BNP Paribas Fortis, said the market could pull back. "After rallying strongly in the past weeks, European equities have become vulnerable to some profit-taking. The largest risk for the stock markets is Trump not delivering on his lofty promises," he said.
Gains in the broader market were capped by weaker commodities stocks. The European oil and gas index fell 0.6 percent, as oil prices were dragged down by uncertainty over whether the Organisation of the Petroleum Exporting Countries will reach an output deal. Miners fell 0.9 percent on a drop in major industrial metals, with Anglo American and Glencore both declining more than 1.5 percent.
Elsewhere, Daily Mail and General Trust slumped 4.3 percent after Barclays lowered its rating on the stock to "underweight" from "equal weight" and cut its target price to 705 pence from 715 pence. Italian bank Monte dei Paschi di Siena fell 13 percent on doubts it would find buyers for a 5 billion-euro share sale that is expected to be launched just after a referendum on Prime Minister Matteo Renzi's constitutional reform plan.

Copyright Reuters, 2016

Comments

Comments are closed.